Metastatic Renal Cell Carcinoma ( mRCC)

DBCOND0123126NeoplasmsUrogenital Diseases

Metastatic Renal Cell Carcinoma ( mRCC) is the indication for 5 drugs in DrugBank. It is covered by 11 curated, structured indications.

Also known as
Metastatic Renal Cell Cancer · Metastatic Renal Cell Carcinoma · Metastatic Renal Cell Carcinoma (mRCC) · Renal Cell Cancer Metastatic · Renal Cell Carcinoma, Metastatic
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT702392008MedDRA10050513UMLSC4721698

What you can answer from here — as of October 23, 2026

5Indicated drugsWith each drug's targets and mechanism
Listed above
11Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
253Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Metastatic Renal Cell Carcinoma ( mRCC) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In